10/25/16 Fimbrion, GSK to develop drug for UTIs:  Fimbrion Therapeutics has partnered with GlaxoSmithKline to develop mannosides, a class of mannose-containing small molecule compounds, for use in preventing and treating urinary tract infections. The agreement creates a joint project between Fimbrion and the Discovery Partnerships with Academia at GSK.

Want to get on the nevbio list?  for information or rsvp to an event

World of ​​blogs

NevBio Blog
John Laub's bio & health science blog.

Biotechblog
Commercial, legal, political and scientific trends in biotechnology

Life Science Nation
Connecting Products, Services & Capital

A NevBio Solutions Partner Since 2007

As the Nevada affiliate of Bio, NevBio can connect you or your organization with State Bio groups, industry leaders and drivers of economic development.

News & noise

NevBio Anounces New Member of Advisory Board:  President of NevBio, John Laub, announced today the addition of Ismail Onat to our Advisory Board for International Initiatives.

Mr. Onat brings a wealth of experience in international business and the development of foreign and US business partnerships. We are very excited about the addition of Mr. Onat and the potential it brings to developing relationships to expand Biotechnology 
companies to Nevada and new relationships to our existing community.

Survey, Healthcare Finance, Reform Top Issues Confronting Hospitals in 2014
Financial challenges again ranked No. 1 on the list of hospital CEOs' top concerns in 2014, according to the American College of Healthcare Executives' annual survey of top issues confronting hospitals. Healthcare reform implementation and governmental mandates ranked next in a tie for second, closely followed by patient safety and quality.

​connect with nevbio today,  increase your opportunities tomorrow!

2017 NevBio Proudly Welcomes Our Newest Premier Sponsor: Genentech 

Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 40 years. Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. 
We are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.